{"name":"CG Oncology, Inc.","slug":"cg-oncology-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":116641000,"netIncome":-160995000,"cash":32490000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNdlhDNXZydEFPYjZkZVBzRnNaZDNPNmp6YWZfamNUWl9fQzNraWFyVVZ3endUbnRoNlV3LUVGQ1J2LXpfQ0g5dGQ5Qm5WZWZvaS10S2d2YnBuTTljYjg3UnJ3TTYyT2hOUlJ0Z0hDaTNkUmwxTDRCQ1NJaHNpWkw4em1ybWFSRmYyeEFib0xXMXQ0d0dqVWJmVXFxa2xveFh5Z1I5VWZrY3FheEYzR2locXE4LTZNblVLQy1UbFFYUndKLTNpWE9yZFdvZll3TUZjTklUTkZlUU52M2hlZ0ZQVzA4NHluRDdUODlmeEZsSVl2Z3FfSmloU0RHc1NsbnMxR3gwM2F2MA?oc=5","date":"2026-03-28","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on These Healthcare Stocks: Gain Therapeutics (GANX), CG Oncology, Inc. (CGON) - The Globe and Mail","headline":"Analysts Are Bullish on These Healthcare Stocks: Gain Therapeutics (GANX), CG Oncology, Inc. (CGON)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPdWpfRE9DNFBKQTFKRXZxU19sY0tFVnM0NGFfVjRTdkxSSDY5OW9fRzZEMjhMWEE2Vkp2S1dha3RjZU1xTVBhcENZbjE2aHRMTW5iU0tydFRKSUREWHBHRUwzWWxVTGQxRjAza1BJaktUTFNtaUE4allvLU14WU0ybWZSMm9zOXVEVnNWY1Y4ckFRajlUendLZU1LSUZFbTZ6VTRpN2ZNYkUzRHFLdlZWakZ2bjZiX18xRVIzYjNRNld5QmQ2cEdqYWswdHJCVzk3Y0s5YS1DYVZwbVlGb1NvMmpvUjNQamhhaEx1SGlGeXdyRUN0SlhvbkJjYkF2dTd4bTktWFZOalQtRTJiTVVOampJZmVNOEV2eG1MV1pXWEpYRlduMWpZSnFnVTVHSWE2TjV4YVhCN2JIX1Z1dkFTZVpqblA5endudkRoeHRDdTdzZw?oc=5","date":"2026-03-25","type":"pipeline","source":"Barchart.com","summary":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | CG Oncology, Janssen, Tyra Biosciences, UroGen Pharma - B","headline":"Non Muscle Invasive Bladder Cancer Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPUFBZVjZTc0VhN29yX3ZtUGRQcDN6X0FOOEF4eTl0TFFlaTlIMVhMc2NrWmFNaHktbnpyd0pPU0ppSHZyZEM0YjFfcTI3TnhOOGFuaE93dnhERGxVWnIwNEhSbG4yZHYzemxzTzJRQ0lIZ3FKV0UzaVFRR3RoVVJJaHM3MS1UQzhsRnJuRUM2UmtOZXVNRUM5OWx1N2F3OEZndVU1ZjIzelNTODEzd1EtU3gweXRuX0IwUlNxVFBpVklFYXlYUWVFclZabXE1c1lGZXVPTGZZeTVFbE9pekxHZ1VVZk1JRjBRT25MTFZQNEptdkhPRWJYdnR1djU3UkxtbmhsLXZYaEpiY1RJdFNn?oc=5","date":"2026-03-24","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on These Healthcare Stocks: Entrada Therapeutics Inc (TRDA), CG Oncology, Inc. (CGON) - The Globe and Mail","headline":"Analysts Are Bullish on These Healthcare Stocks: Entrada Therapeutics Inc (TRDA), CG Oncology, Inc. (CGON)","sentiment":"neutral"},{"date":"2026-02-27","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQWW9ZOXBNcHB6V2laTkJpSVdaN0loRERyOXk2ZHR1TEpYaVM2OHVac3lWd29PeTV3SVF3V2lQRS1tZ2xlSnJOU19QM3haekc3OEtFbVJTU0hyUm1iVXRaM2o3NGg5S19kcHpLMVVfdV9RRmQ3dzU1eEJSS2hqU0ZsTVNYWUc?oc=5","date":"2026-01-15","type":"pipeline","source":"Yahoo Finance","summary":"CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why - Yahoo Finance","headline":"CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why","sentiment":"neutral"},{"date":"2026-01-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOaS1NdklVbVpmOUZ2dF8zLWxzc21vc3YybTdfcW1OVmkxekpLSExTR1JfclBkUEZNUHNaQkxDVFhuVTZ3YjZ4Vm5Nc09BZUtYd2Y5MHNfYzh5SnYyZ080RWcxV2FraUZCd1VHNFFDa1BBYVctbmRvc0FjLVZqVG9oYmRucHhtYWdidktEM3huZXVfaWUxc1VJNFZ0cHo1TjVyMGdjbWlwc1c0VGlkdDFtU1lCUFZqblplSW5CNENGODZRNkhKN19rSWl3WnZvUmZGX1JCZmVBRjNLcXc?oc=5","date":"2026-01-12","type":"regulatory","source":"PR Newswire","summary":"Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 - PR Newswire","headline":"Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNcDVaY3JwUlRYMXQwMjNCNmV6US1lS2hCMHQ0aTh4QnpuZ01OczBmV3FUc0NhM29ucmgwNFN4Yy1ncmdHLXZmSGFsNUlXNDN4NWFPb3BBcTYtdEFCQ2RVWlUwYUlTeUVLemFrZWdaQ1JLQUdicTNEZ3dUQ3VvblRQb0YxSE1TamN0dVRIV0VzbTB1TFRmdEFPZHZoX0s1d0VPTktVMkNIWGF6ZHBrTU1HNFdkT01aYnNJS2ZLMUM0VmZ4ZjRLSUJQY0JwS2lSTDgydldnM1pqc3V2LUJrS1NvZ2Jn?oc=5","date":"2026-01-09","type":"pipeline","source":"Benzinga","summary":"CG Oncology, Rich Sparkle Holdings, Liquidia And Other Big Stocks Moving Higher On Friday - Benzinga","headline":"CG Oncology, Rich Sparkle Holdings, Liquidia And Other Big Stocks Moving Higher On Friday","sentiment":"neutral"},{"date":"2026-01-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPZ3Mta3RIUHFwY3FKMzM1b001ZkF2T3hSY24wckR2bVozcEZ0djA5X25jS1A2cmFnV3ZRWHNLd2FUQVBPa0dMVTdOR2FOTHVIcXdfYmpfR1BrejdPbTJoSUg1TF9MdmhsMENuYTY1a1VsZXpsVnZ1ZU1jb1llbkx6RG9FLVhHbFV1MFFDd19R?oc=5","date":"2025-12-23","type":"pipeline","source":"Seeking Alpha","summary":"CG Oncology Undervalued Going Into A Busy 2026 (NASDAQ:CGON) - Seeking Alpha","headline":"CG Oncology Undervalued Going Into A Busy 2026 (NASDAQ:CGON)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOa3FyVXNvaFdDbUpYNV9uWUhPeDNWSnA4S2tqVFlMZTBoeXkteWJlUzBELV9oRENYZzhxSW5zVUxtUUJkV2tlOTV0dVoycFlzWkd1ZGJ0RnFYam1vNzRSV0xwYmNyc0lMemIxYUdmdEd2LUhfQXlMSzd0Q1VlR1ExdExDRUtrdUd0bjRHc1FneThkcV9LcFE?oc=5","date":"2025-11-26","type":"pipeline","source":"Quiver Quantitative","summary":"CG Oncology Appoints Christina Rossi to Board of Directors - Quiver Quantitative","headline":"CG Oncology Appoints Christina Rossi to Board of Directors","sentiment":"neutral"},{"date":"2025-11-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":116641000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-160995000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":32490000,"cashHistory":[],"totalAssets":791592000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}